TrovaGene

TrovaGene

TrovaGene

Trovagene’s Precision Cancer Monitoring technology allows physicians to monitor cancer treatment status with a simple urine or blood test. #liquidbiopsy
Founded
1999
Raised
$22.1M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$7,100,000
Post-IPO equity - 2017
$15,000,000
Debt financing - 2014
Team Size
10+
Employees
$7,100,000 Post-IPO equity
Drug Delivery Business

Trovagene raises $7m for precision cancer therapies